BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28718430)

  • 1. Liquid Biopsies in Colorectal Cancer: Monitoring Genetic Heterogeneity.
    Gargalionis AN; Papavassiliou AG
    Trends Cancer; 2017 Mar; 3(3):166-168. PubMed ID: 28718430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of liquid biopsies in colorectal cancer.
    Wills B; Gorse E; Lee V
    Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives of the Application of Liquid Biopsy in Colorectal Cancer.
    Ding Y; Li W; Wang K; Xu C; Hao M; Ding L
    Biomed Res Int; 2020; 2020():6843180. PubMed ID: 32258135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy challenge and hope in colorectal cancer.
    Burz C; Rosca A; Pop VV; Buiga R; Aldea C; Samasca G; Silaghi C; Sur D; Lupan I; Pricopie A
    Expert Rev Mol Diagn; 2019 Apr; 19(4):341-348. PubMed ID: 30943811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of circulating tumor DNA in the management of patients with colorectal cancer.
    Moati E; Taly V; Didelot A; Perkins G; Blons H; Taieb J; Laurent-Puig P; Zaanan A
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):396-402. PubMed ID: 29627453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
    Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
    Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer case.
    Appierto V; Di Cosimo S; Reduzzi C; Pala V; Cappelletti V; Daidone MG
    Semin Cancer Biol; 2017 Jun; 44():106-116. PubMed ID: 28442298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities of liquid biopsy in gastric cancer].
    Zakharenko AA; Zaitsev DA; Belyaev MA; Trushin AA; Ten OA; Natkha AS
    Vopr Onkol; 2016; 62(4):379-85. PubMed ID: 30474943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of circulating biomarkers in liquid biopsy diagnostics.
    Yeo JC; Lim CT
    Biotechniques; 2018 Oct; 65(4):187-189. PubMed ID: 30284936
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review.
    Vymetalkova V; Cervena K; Bartu L; Vodicka P
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor DNA as a marker of minimal residual disease in colorectal cancer.
    Kopetz S
    Clin Adv Hematol Oncol; 2020 Dec; 18(12):791-792. PubMed ID: 33406055
    [No Abstract]   [Full Text] [Related]  

  • 12. "Liquid Biopsy" - Is it a Feasible Option in Colorectal Cancer?
    Scripcariu V; Scripcariu DV; Filip B; Gavrilescu MM; Muşină AM; Volovăţ C
    Chirurgia (Bucur); 2019; 114(2):162-166. PubMed ID: 31060647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Cancer Therapy: Liquid Biopsy.
    Marmé D
    Oncol Res Treat; 2017; 40(7-8):402-403. PubMed ID: 28728143
    [No Abstract]   [Full Text] [Related]  

  • 14. Liquid biopsies: Potential and challenges.
    Heidrich I; Ačkar L; Mossahebi Mohammadi P; Pantel K
    Int J Cancer; 2021 Feb; 148(3):528-545. PubMed ID: 32683679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy: novel technologies and clinical applications.
    Reimers N; Pantel K
    Clin Chem Lab Med; 2019 Feb; 57(3):312-316. PubMed ID: 30465714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial.
    Bidard FC; Kiavue N; Ychou M; Cabel L; Stern MH; Madic J; Saliou A; Rampanou A; Decraene C; Bouché O; Rivoire M; Ghiringhelli F; Francois E; Guimbaud R; Mineur L; Khemissa-Akouz F; Mazard T; Moussata D; Proudhon C; Pierga JY; Stanbury T; Thézenas S; Mariani P
    Cells; 2019 May; 8(6):. PubMed ID: 31142037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating biomarkers for early detection and clinical management of colorectal cancer.
    Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
    Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy for cancer diagnosis and screening - The promise and challenges.
    Thorat MA
    Ann Clin Biochem; 2019 Jul; 56(4):420-423. PubMed ID: 30971101
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
    Junqueira-Neto S; Batista IA; Costa JL; Melo SA
    Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.